Shanghai Henlius Biotech, Inc. Class H (HK:2696) has released an update.
Shanghai Henlius Biotech, Inc. has approved amended and restated articles of association, detailing the company’s structure, share management, and financial regulations. Key areas covered include the issuance, transfer, and repurchase of shares, as well as governance related to board and shareholder meetings. The comprehensive document outlines the company’s operational framework, including the roles of directors and senior management, and procedures for financial management and corporate actions.
For further insights into HK:2696 stock, check out TipRanks’ Stock Analysis page.
